Skip to main content
Erschienen in: Diabetologia 5/2007

01.05.2007 | Article

In utero undernutrition reduces diabetes incidence in non-obese diabetic mice

verfasst von: A. Oge, E. Isganaitis, J. Jimenez-Chillaron, C. Reamer, R. Faucette, K. Barry, R. Przybyla, M. E. Patti

Erschienen in: Diabetologia | Ausgabe 5/2007

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Observational studies in humans suggest that low birthweight may decrease the risk of type 1 diabetes, but the mechanism is unknown. We hypothesised that antenatal undernutrition would decrease the incidence of type 1 diabetes in non-obese diabetic (NOD) mice.

Materials and methods

A 40% restriction of energy intake was applied to pregnant NOD dams from day 12.5 to day 18.5 of gestation, resulting in intrauterine growth retardation of offspring. All mice were fed a standard diet after weaning. Control and undernourished female offspring were followed to assess diabetes incidence. Male NOD mice were treated with cyclophosphamide to accelerate development of diabetes. Glucose homeostasis, body composition and pancreatic histology were compared in control and undernourished offspring.

Results

Mean birthweight was lower in undernourished than in control mice (p = 0.00003). At 24 weeks of age, the cumulative incidence of spontaneous diabetes in female mice was 73% in control and 48% in undernourished mice (p = 0.003). In cyclophosphamide-treated male mice, antenatal undernutrition also tended to reduce the development of diabetes (p = 0.058). Maternal leptin levels were lower in undernourished dams on day 18.5 of pregnancy (p = 0.039), while postnatal leptin levels were significantly higher in undernourished offspring at 4, 20 and 27 weeks of life (p < 0.05). Beta cell mass was similar in both groups (control  =  0.4 mg; undernourished  =  0.54 mg; p = 0.24). Histological evidence of apoptosis at 20 weeks was greater in control than in undernourished mice (control  =  6.3 ± 1.4%; undernourished  =  4.2 ± 0.3%, p = 0.05).

Conclusions/interpretation

Antenatal undernutrition reduces the incidence of diabetes in NOD mice, perhaps via alterations in apoptosis.
Literatur
1.
Zurück zum Zitat Gluckman PD, Hanson MA (2004) Living with the past: evolution, development, and patterns of disease. Science 305:1733–1736PubMedCrossRef Gluckman PD, Hanson MA (2004) Living with the past: evolution, development, and patterns of disease. Science 305:1733–1736PubMedCrossRef
2.
Zurück zum Zitat Stene LC, Magnus P, Lie RT, Sovik O, Joner G; Norwegian Childhood Diabetes Study Group (2001) Birth weight and childhood onset type 1 diabetes: population based cohort study. BMJ 322:889–892PubMedCrossRef Stene LC, Magnus P, Lie RT, Sovik O, Joner G; Norwegian Childhood Diabetes Study Group (2001) Birth weight and childhood onset type 1 diabetes: population based cohort study. BMJ 322:889–892PubMedCrossRef
3.
Zurück zum Zitat Dahlquist GG, Patterson C, Soltesz G (1999) Perinatal risk factors for childhood type 1 diabetes in Europe. The EURODIAB Substudy 2 Study Group. Diabetes Care 22:1698–1702PubMedCrossRef Dahlquist GG, Patterson C, Soltesz G (1999) Perinatal risk factors for childhood type 1 diabetes in Europe. The EURODIAB Substudy 2 Study Group. Diabetes Care 22:1698–1702PubMedCrossRef
4.
Zurück zum Zitat Podar T, Onkamo P, Forsen T, Karvonen M, Tuomilehto-Wolf E, Tuomilehto J (1999) Neonatal anthropometric measurements and risk of childhood-onset type 1 diabetes. DiMe Study Group. Diabetes Care 22:2092–2094PubMedCrossRef Podar T, Onkamo P, Forsen T, Karvonen M, Tuomilehto-Wolf E, Tuomilehto J (1999) Neonatal anthropometric measurements and risk of childhood-onset type 1 diabetes. DiMe Study Group. Diabetes Care 22:2092–2094PubMedCrossRef
5.
Zurück zum Zitat Rich-Edwards JW, Colditz GA, Stampfer MJ et al (1999) Birthweight and the risk for type 2 diabetes mellitus in adult women. Ann Intern Med 130:278–284PubMed Rich-Edwards JW, Colditz GA, Stampfer MJ et al (1999) Birthweight and the risk for type 2 diabetes mellitus in adult women. Ann Intern Med 130:278–284PubMed
6.
Zurück zum Zitat Dahlquist G, Bennich SS, Kallen B (1996) Intrauterine growth pattern and risk of childhood onset insulin dependent (type I) diabetes: population based case-control study. BMJ 313:1174–1177PubMed Dahlquist G, Bennich SS, Kallen B (1996) Intrauterine growth pattern and risk of childhood onset insulin dependent (type I) diabetes: population based case-control study. BMJ 313:1174–1177PubMed
7.
Zurück zum Zitat Cardwell CR, Carson DJ, Patterson CC (2005) Parental age at delivery, birth order, birth weight and gestational age are associated with the risk of childhood Type 1 diabetes: a UK regional retrospective cohort study. Diabet Med 22:200–206PubMedCrossRef Cardwell CR, Carson DJ, Patterson CC (2005) Parental age at delivery, birth order, birth weight and gestational age are associated with the risk of childhood Type 1 diabetes: a UK regional retrospective cohort study. Diabet Med 22:200–206PubMedCrossRef
8.
Zurück zum Zitat Dorner G, Thoelke H, Mohnike A, Schneider H (1985) High food supply in perinatal life appears to favour the development of insulin-treated diabetes mellitus (ITDM) in later life. Exp Clin Endocrinol 85:1–6PubMedCrossRef Dorner G, Thoelke H, Mohnike A, Schneider H (1985) High food supply in perinatal life appears to favour the development of insulin-treated diabetes mellitus (ITDM) in later life. Exp Clin Endocrinol 85:1–6PubMedCrossRef
9.
Zurück zum Zitat Kimpimaki T, Kulmala P, Savola K et al (2002) Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 87:4572–4579PubMedCrossRef Kimpimaki T, Kulmala P, Savola K et al (2002) Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 87:4572–4579PubMedCrossRef
10.
Zurück zum Zitat Johansson C, Samuelsson U, Ludvigsson J (1994) A high weight gain early in life is associated with an increased risk of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 37:91–94PubMed Johansson C, Samuelsson U, Ludvigsson J (1994) A high weight gain early in life is associated with an increased risk of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 37:91–94PubMed
11.
Zurück zum Zitat Blom L, Persson LA, Dahlquist G (1992) A high linear growth is associated with an increased risk of childhood diabetes mellitus. Diabetologia 35:528–533PubMedCrossRef Blom L, Persson LA, Dahlquist G (1992) A high linear growth is associated with an increased risk of childhood diabetes mellitus. Diabetologia 35:528–533PubMedCrossRef
12.
Zurück zum Zitat Bao M, Yang Y, Jun HS, Yoon JW (2002) Molecular mechanisms for gender differences in susceptibility to T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Immunol 168:5369–5375PubMed Bao M, Yang Y, Jun HS, Yoon JW (2002) Molecular mechanisms for gender differences in susceptibility to T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Immunol 168:5369–5375PubMed
13.
Zurück zum Zitat Harada M, Makino S (1984) Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia 27:604–606PubMedCrossRef Harada M, Makino S (1984) Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia 27:604–606PubMedCrossRef
14.
Zurück zum Zitat Matsumoto M, Yagi H, Kunimoto K, Kawaguchi J, Makino S, Harada M (1993) Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis. Cell Immunol 148:189–197PubMedCrossRef Matsumoto M, Yagi H, Kunimoto K, Kawaguchi J, Makino S, Harada M (1993) Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis. Cell Immunol 148:189–197PubMedCrossRef
15.
Zurück zum Zitat Montana E, Bonner-Weir S, Weir GC (1993) Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozotocin diabetic C57BL/6 mice. J Clin Invest 91:780–787PubMedCrossRef Montana E, Bonner-Weir S, Weir GC (1993) Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozotocin diabetic C57BL/6 mice. J Clin Invest 91:780–787PubMedCrossRef
16.
Zurück zum Zitat Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493–501PubMedCrossRef Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493–501PubMedCrossRef
17.
Zurück zum Zitat Jimenez-Chillaron JC, Hernandez-Valencia M, Reamer C et al (2005) Beta-cell secretory dysfunction in the pathogenesis of low birth weight-associated diabetes: a murine model. Diabetes 54:702–711PubMedCrossRef Jimenez-Chillaron JC, Hernandez-Valencia M, Reamer C et al (2005) Beta-cell secretory dysfunction in the pathogenesis of low birth weight-associated diabetes: a murine model. Diabetes 54:702–711PubMedCrossRef
18.
Zurück zum Zitat Jimenez-Chillaron JC, Hernandez-Valencia M, Lightner A et al (2006) Reductions in caloric intake and early postnatal growth prevent glucose intolerance and obesity associated with low birthweight. Diabetologia 49:1974–1984PubMedCrossRef Jimenez-Chillaron JC, Hernandez-Valencia M, Lightner A et al (2006) Reductions in caloric intake and early postnatal growth prevent glucose intolerance and obesity associated with low birthweight. Diabetologia 49:1974–1984PubMedCrossRef
19.
Zurück zum Zitat Lampeter EF, Signore A, Gale EA, Pozzilli P (1989) Lessons from the NOD mouse for the pathogenesis and immunotherapy of human type 1 (insulin-dependent) diabetes mellitus. Diabetologia 32:703–708PubMedCrossRef Lampeter EF, Signore A, Gale EA, Pozzilli P (1989) Lessons from the NOD mouse for the pathogenesis and immunotherapy of human type 1 (insulin-dependent) diabetes mellitus. Diabetologia 32:703–708PubMedCrossRef
20.
Zurück zum Zitat Augstein P, Elefanty AG, Allison J, Harrison LC (1998) Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes. Diabetologia 41:1381–1388PubMedCrossRef Augstein P, Elefanty AG, Allison J, Harrison LC (1998) Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes. Diabetologia 41:1381–1388PubMedCrossRef
21.
Zurück zum Zitat Scaglia L, Cahill CJ, Finegood DT, Bonner-Weir S (1997) Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology 138:1736–1741PubMedCrossRef Scaglia L, Cahill CJ, Finegood DT, Bonner-Weir S (1997) Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology 138:1736–1741PubMedCrossRef
22.
Zurück zum Zitat Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115:911–919PubMedCrossRef Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115:911–919PubMedCrossRef
23.
Zurück zum Zitat Andre-Schmutz I, Hindelang C, Benoist C, Mathis D (1999) Cellular and molecular changes accompanying the progression from insulitis to diabetes. Eur J Immunol 29:245–255PubMedCrossRef Andre-Schmutz I, Hindelang C, Benoist C, Mathis D (1999) Cellular and molecular changes accompanying the progression from insulitis to diabetes. Eur J Immunol 29:245–255PubMedCrossRef
24.
Zurück zum Zitat Matos M, Park R, Mathis D, Benoist C (2004) Progression to islet destruction in a cyclophosphamide-induced transgenic model: a microarray overview. Diabetes 53:2310–2321PubMedCrossRef Matos M, Park R, Mathis D, Benoist C (2004) Progression to islet destruction in a cyclophosphamide-induced transgenic model: a microarray overview. Diabetes 53:2310–2321PubMedCrossRef
25.
Zurück zum Zitat Seufert J (2004) Leptin effects on pancreatic beta-cell gene expression and function. Diabetes 53(Suppl 1):S152–S158PubMedCrossRef Seufert J (2004) Leptin effects on pancreatic beta-cell gene expression and function. Diabetes 53(Suppl 1):S152–S158PubMedCrossRef
26.
Zurück zum Zitat Okuya S, Tanabe K, Tanizawa Y, Oka Y (2001) Leptin increases the viability of isolated rat pancreatic islets by suppressing apoptosis. Endocrinology 142:4827–4830PubMedCrossRef Okuya S, Tanabe K, Tanizawa Y, Oka Y (2001) Leptin increases the viability of isolated rat pancreatic islets by suppressing apoptosis. Endocrinology 142:4827–4830PubMedCrossRef
27.
Zurück zum Zitat Matarese G, Sanna V, Lechler RI et al (2002) Leptin accelerates autoimmune diabetes in female NOD mice. Diabetes 51:1356–1361PubMedCrossRef Matarese G, Sanna V, Lechler RI et al (2002) Leptin accelerates autoimmune diabetes in female NOD mice. Diabetes 51:1356–1361PubMedCrossRef
28.
Zurück zum Zitat Lee CH, Reifsnyder PC, Naggert JK et al (2005) Novel leptin receptor mutation in NOD/LtJ mice suppresses type 1 diabetes progression: I. Pathophysiological analysis. Diabetes 54:2525–2532PubMedCrossRef Lee CH, Reifsnyder PC, Naggert JK et al (2005) Novel leptin receptor mutation in NOD/LtJ mice suppresses type 1 diabetes progression: I. Pathophysiological analysis. Diabetes 54:2525–2532PubMedCrossRef
29.
Zurück zum Zitat Kamoda T, Saitoh H, Saito M, Sugiura M, Matsui A (2004) Serum adiponectin concentrations in newborn infants in early postnatal life. Pediatr Res 56:690–693PubMedCrossRef Kamoda T, Saitoh H, Saito M, Sugiura M, Matsui A (2004) Serum adiponectin concentrations in newborn infants in early postnatal life. Pediatr Res 56:690–693PubMedCrossRef
30.
Zurück zum Zitat Sennello JA, Fayad R, Morris AM et al (2005) Regulation of T cell-mediated hepatic inflammation by adiponectin and leptin. Endocrinology 146:2157–2164PubMedCrossRef Sennello JA, Fayad R, Morris AM et al (2005) Regulation of T cell-mediated hepatic inflammation by adiponectin and leptin. Endocrinology 146:2157–2164PubMedCrossRef
31.
Zurück zum Zitat Aaen K, Rygaard J, Josefsen K et al (1990) Dependence of antigen expression on functional state of beta-cells. Diabetes 39:697–701PubMedCrossRef Aaen K, Rygaard J, Josefsen K et al (1990) Dependence of antigen expression on functional state of beta-cells. Diabetes 39:697–701PubMedCrossRef
32.
Zurück zum Zitat Diabetes Prevention Trial-Type 1 Diabetes Study Group (2002) Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 346:1685–1691CrossRef Diabetes Prevention Trial-Type 1 Diabetes Study Group (2002) Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 346:1685–1691CrossRef
33.
Zurück zum Zitat Petry CJ, Ozanne SE, Wang CL, Hales CN (2000) Effects of early protein restriction and adult obesity on rat pancreatic hormone content and glucose tolerance. Horm Metab Res 32:233–239PubMedCrossRef Petry CJ, Ozanne SE, Wang CL, Hales CN (2000) Effects of early protein restriction and adult obesity on rat pancreatic hormone content and glucose tolerance. Horm Metab Res 32:233–239PubMedCrossRef
34.
Zurück zum Zitat Simmons RA, Templeton LJ, Gertz SJ (2001) Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes 50:2279–2286PubMedCrossRef Simmons RA, Templeton LJ, Gertz SJ (2001) Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes 50:2279–2286PubMedCrossRef
35.
Zurück zum Zitat Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR (1999) Tissue-specific knockout of the insulin receptor in pancreatic b cells creates an insulin secretory defect similar to that in Type 2 diabetes. Cell 96:329–339PubMedCrossRef Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR (1999) Tissue-specific knockout of the insulin receptor in pancreatic b cells creates an insulin secretory defect similar to that in Type 2 diabetes. Cell 96:329–339PubMedCrossRef
36.
Zurück zum Zitat Fukuhara A, Matsuda M, Nishizawa M et al (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307:426–430PubMedCrossRef Fukuhara A, Matsuda M, Nishizawa M et al (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307:426–430PubMedCrossRef
37.
Zurück zum Zitat Lawler-Heavner J, Cruickshanks KJ, Hay WW, Gay EC, Hamman RF (1994) Birth size and risk of insulin-dependent diabetes mellitus (IDDM). Diabetes Res Clin Pract 24:153–159PubMedCrossRef Lawler-Heavner J, Cruickshanks KJ, Hay WW, Gay EC, Hamman RF (1994) Birth size and risk of insulin-dependent diabetes mellitus (IDDM). Diabetes Res Clin Pract 24:153–159PubMedCrossRef
38.
Zurück zum Zitat Bock T, Pedersen CR, Volund A, Pallesen CS, Buschard K (1994) Perinatal determinants among children who later develop IDDM. Diabetes Care 17:1154–1157PubMedCrossRef Bock T, Pedersen CR, Volund A, Pallesen CS, Buschard K (1994) Perinatal determinants among children who later develop IDDM. Diabetes Care 17:1154–1157PubMedCrossRef
39.
Zurück zum Zitat Dahlquist GG, Pundziute-Lycka A, Nystrom L (2005) Birthweight and risk of type 1 diabetes in children and young adults: a population-based register study. Diabetologia 48:1114–1117PubMedCrossRef Dahlquist GG, Pundziute-Lycka A, Nystrom L (2005) Birthweight and risk of type 1 diabetes in children and young adults: a population-based register study. Diabetologia 48:1114–1117PubMedCrossRef
40.
Zurück zum Zitat Larsson HE, Lynch K, Lernmark B et al (2005) Diabetes-associated HLA genotypes affect birthweight in the general population. Diabetologia 48:1484–1491PubMedCrossRef Larsson HE, Lynch K, Lernmark B et al (2005) Diabetes-associated HLA genotypes affect birthweight in the general population. Diabetologia 48:1484–1491PubMedCrossRef
41.
Zurück zum Zitat Pedersen CR, Hagemann I, Bock T, Buschard K (1999) Intermittent feeding and fasting reduces diabetes incidence in BB rats. Autoimmunity 30:243–250PubMed Pedersen CR, Hagemann I, Bock T, Buschard K (1999) Intermittent feeding and fasting reduces diabetes incidence in BB rats. Autoimmunity 30:243–250PubMed
42.
Zurück zum Zitat Schneider K, Laube H, Linn T (1996) A diet enriched in protein accelerates diabetes manifestation in NOD mice. Acta Diabetol 33:236–240PubMed Schneider K, Laube H, Linn T (1996) A diet enriched in protein accelerates diabetes manifestation in NOD mice. Acta Diabetol 33:236–240PubMed
43.
Zurück zum Zitat Linn T, Strate C, Schneider K (1999) Diet promotes beta-cell loss by apoptosis in prediabetic nonobese diabetic mice. Endocrinology 140:3767–3773PubMedCrossRef Linn T, Strate C, Schneider K (1999) Diet promotes beta-cell loss by apoptosis in prediabetic nonobese diabetic mice. Endocrinology 140:3767–3773PubMedCrossRef
44.
Zurück zum Zitat Shimabukuro M, Wang MY, Zhou YT, Newgard CB, Unger RH (1998) Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression. Proc Natl Acad Sci U S A 95:9558–9561PubMedCrossRef Shimabukuro M, Wang MY, Zhou YT, Newgard CB, Unger RH (1998) Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression. Proc Natl Acad Sci U S A 95:9558–9561PubMedCrossRef
45.
Zurück zum Zitat Piro S, Anello M, Di Pietro C et al (2002) Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress. Metabolism 51:1340–1347PubMedCrossRef Piro S, Anello M, Di Pietro C et al (2002) Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress. Metabolism 51:1340–1347PubMedCrossRef
46.
Zurück zum Zitat Thilaganathan B, Plachouras N, Makrydimas G, Nicolaides KH (1993) Fetal immunodeficiency: a consequence of placental insufficiency. Br J Obstet Gynaecol 100:1000–1004PubMed Thilaganathan B, Plachouras N, Makrydimas G, Nicolaides KH (1993) Fetal immunodeficiency: a consequence of placental insufficiency. Br J Obstet Gynaecol 100:1000–1004PubMed
47.
Zurück zum Zitat McDade TW, Beck MA, Kuzawa C, Adair LS (2001) Prenatal undernutrition, postnatal environments, and antibody response to vaccination in adolescence. Am J Clin Nutr 74:543–548PubMed McDade TW, Beck MA, Kuzawa C, Adair LS (2001) Prenatal undernutrition, postnatal environments, and antibody response to vaccination in adolescence. Am J Clin Nutr 74:543–548PubMed
48.
Zurück zum Zitat Wilder RL (1995) Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol 13:307–338PubMedCrossRef Wilder RL (1995) Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol 13:307–338PubMedCrossRef
49.
Zurück zum Zitat Kagohashi Y, Udagawa J, Abiru N, Kobayashi M, Moriyama K, Otani H (2005) Maternal factors in a model of type 1 diabetes differentially affect the development of insulitis and overt diabetes in offspring. Diabetes 54:2026–2031PubMedCrossRef Kagohashi Y, Udagawa J, Abiru N, Kobayashi M, Moriyama K, Otani H (2005) Maternal factors in a model of type 1 diabetes differentially affect the development of insulitis and overt diabetes in offspring. Diabetes 54:2026–2031PubMedCrossRef
Metadaten
Titel
In utero undernutrition reduces diabetes incidence in non-obese diabetic mice
verfasst von
A. Oge
E. Isganaitis
J. Jimenez-Chillaron
C. Reamer
R. Faucette
K. Barry
R. Przybyla
M. E. Patti
Publikationsdatum
01.05.2007
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 5/2007
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-007-0617-0

Weitere Artikel der Ausgabe 5/2007

Diabetologia 5/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Chronisches Koronarsyndrom: Gefahr von Hospitalisierung wegen Herzinsuffizienz

06.05.2024 Herzinsuffizienz Nachrichten

Obwohl ein rezidivierender Herzinfarkt bei chronischem Koronarsyndrom wahrscheinlich die Hauptsorge sowohl der Patienten als auch der Ärzte ist, sind andere Ereignisse womöglich gefährlicher. Laut einer französischen Studie stellt eine Hospitalisation wegen Herzinsuffizienz eine größere Gefahr dar.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

06.05.2024 Insomnie Nachrichten

Chronische Insomnie als eigenständiges Krankheitsbild ernst nehmen und adäquat nach dem aktuellen Forschungsstand behandeln: Das forderte der Schlafmediziner Dr. Dieter Kunz von der Berliner Charité beim Praxis Update.

GLP-1-Rezeptoragonisten und SGLT-2-Hemmer: zusammen besser

06.05.2024 Typ-2-Diabetes Nachrichten

Immer häufiger wird ein Typ-2-Diabetes sowohl mit einem GLP-1-Rezeptor-Agonisten als auch mit einem SGLT-2-Inhibitor behandelt. Wie sich das verglichen mit den Einzeltherapien auf kardiovaskuläre und renale Komplikationen auswirkt, wurde anhand von Praxisdaten aus Großbritannien untersucht.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.